Evaluation and Disruption of Tau - GSK3β Vicious Cycle
Tau 的评估和破坏 - GSK3β 恶性循环
基本信息
- 批准号:10398663
- 负责人:
- 金额:$ 0.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAdverse effectsAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAntisense OligonucleotidesAxonal TransportBindingBlood - brain barrier anatomyBrainCellsDataDevelopmentDiseaseDisease ProgressionDoseEnterobacteria phage P1 Cre recombinaseEvaluationExcisionExposure toGoalsHumanImmuneImpaired cognitionKnockout MiceLeadLearningMaintenanceMediatingMemoryMemory impairmentModelingMusNerve DegenerationNeurogliaNeuronsPathogenesisPathogenicityPathway interactionsPenetrationPhosphotransferasesPreclinical TestingProcessProtein KinaseProteinsSafetySignal TransductionTauopathiesTestingTherapeuticTransgenic OrganismsViral Vectorexcitatory neuronexcitotoxicityexperimental studyin vivomouse modelmutantneuron lossneuronal survivaloffspringpreventpromoterprotein kinase inhibitorrhotau Proteinstau expressiontau mutation
项目摘要
Project Summary/Abstract
Our goal is to advance our understanding and ability to treat Alzheimer's disease. Our lab discovered that tau
reduction can prevent A-induced activation of GSK3, a kinase that is activated by many AD-relevant
pathomechanisms and has been implicated in the hyperphosphorylation of tau. We will determine which of
these mechanisms activate GSK3β in a tau-dependent manner and whether the activation involves direct
interactions between tau and GSK3β. To prevent tau-dependent GSK3 activation, we propose to reduce
overall tau levels. Tau reduction can prevent cognitive decline and neurodegeneration in mouse models of AD.
We found that blocking the rho-associated protein kinase (ROCK) pathway reduces tau levels in primary cells
and in adult mouse brain. To further explore this therapeutic strategy, we will use a new ROCK inhibitor that
has high potency and good brain penetration in mouse models.
项目总结/文摘
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Generating Custom Pooled CRISPR Libraries for Genetic Dissection of Biological Pathways.
生成用于生物途径遗传解析的定制 CRISPR 文库。
- DOI:10.1007/978-1-0716-2209-4_21
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Gulbranson,DanielR
- 通讯作者:Gulbranson,DanielR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Gulbranson其他文献
Daniel Gulbranson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Gulbranson', 18)}}的其他基金
Evaluation and Disruption of Tau - GSK3ò Vicious Cycle
Tau 的评估和破坏 - GSK3™ 恶性循环
- 批准号:
10237411 - 财政年份:2019
- 资助金额:
$ 0.25万 - 项目类别:
Evaluation and Disruption of Tau - GSK3β Vicious Cycle
Tau 的评估和破坏 - GSK3β 恶性循环
- 批准号:
10075784 - 财政年份:2019
- 资助金额:
$ 0.25万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 0.25万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 0.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 0.25万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 0.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 0.25万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 0.25万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 0.25万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 0.25万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 0.25万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 0.25万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




